Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net income	$ 18,223,000	$ 22,113,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	4,506,000	4,469,000
Deferred income taxes	(118,000)	(721,000)
Reserve for uncertain tax positions	211,000	250,000
Non-cash share-based compensation expense	96,000	677,000
Change in fair value of contingent consideration	23,000	0
Net changes in assets and liabilities:
Trade accounts receivable	1,752,000	(6,000)
Prepaid expenses and other current assets	91,000	(3,257,000)
Deferred contract costs, net	212,000	800,000
Operating lease assets and liabilities, net	9,000	(75,000)
Accounts payable	599,000	230,000
Accrued expenses, wages and bonuses	1,789,000	493,000
Income taxes receivable and payable	(706,000)	392,000
Deferred revenue	1,559,000	1,040,000
Net cash provided by operating activities	28,246,000	26,405,000
Cash flows from investing activities:
Purchases of property and equipment	(11,004,000)	(12,009,000)
Acquisitions, net of cash acquired	(4,833,000)	0
Proceeds from the sale of property and equipment	0	1,000
Net cash used in investing activities	(15,837,000)	(12,008,000)
Cash flows from financing activities:
Payments on notes payable	(5,044,000)	(3,373,000)
Borrowings on notes payable	17,000,000	0
Borrowings on line of credit	39,000,000	5,000,000
Payments on line of credit	(34,000,000)	0
Payments on finance lease obligations	(19,000)	(279,000)
Payment of debt issuance costs	37,000	8,000
Proceeds from the exercise of share-based awards	0	584,000
Payment of payroll tax withholdings on share-based awards exercised	(317,000)	0
Repurchase of shares for treasury	23,548,000	4,100,000
Payment of dividends on common stock	(8,636,000)	(33,419,000)
Net cash used in financing activities	(15,601,000)	(35,595,000)
Change in cash and cash equivalents	(3,192,000)	(21,198,000)
Cash and cash equivalents at beginning of period	6,653,000	25,026,000
Cash and cash equivalents at end of period	3,461,000	3,828,000
Supplemental disclosure of cash paid for:
Interest expense, net of capitalized amounts	1,699,000	600,000
Income taxes	6,270,000	6,484,000
Supplemental disclosure of non-cash investing and financing activities:
Stock tendered to the Company for cashless exercise of stock options in connection with equity incentive plans	1,752,000	0
Purchase of property and equipment in accounts payable and accrued expenses	2,610,000	1,819,000
Repurchase of shares for treasury in accounts payable and accrued expenses	238,000	24,000
Contingent consideration recorded in connection with acquisition	$ 776,000	$ 0